Table 2.
Variable | n (%) | Crude PR (95CI) | p | Adjusted PR (95CI) | p |
---|---|---|---|---|---|
Genderc,f | |||||
Female | 27 (16.0) | 1 | 0.001 | 1 | 0.001 |
Male | 71 (40.8) | 2.55 (1.73–3.77) | 2.88 (1.96–4.24) | ||
Agec,f | |||||
18–34 | 27 (27.3) | 1 | 0.5b | 1 | 0.08a |
35–54 | 59 (30.7) | 1.13 (0.76–1.66) | 0.81 (0.56–1.16) | ||
55 or older | 12 (23.1) | 0.85 (0.47–1.53) | 0.61 (0.34–1.10) | ||
Skin colorc,f | |||||
White | 60 (25.2) | 1 | 0.01a | 1 | 0.04a |
Mixed | 17 (30.9) | 1.23 (0.80–1.93) | 1.10 (0.74–1.65) | ||
Black | 21 (42.0) | 1.67 (1.12–2.47) | 1.44 (0.98–2.13) | ||
Educationc,f | |||||
Each year | 0.93 (0.89–0.98) | 0.005 | 0.95 (0.90–0.99) | 0.03 | |
Income (quartiles)c,f | |||||
1st | 22 (23.7) | 1 | 0.006b | 1 | 0.003b |
2nd | 33 (40.2) | 1.70 (1.08–2.67) | 1.67 (1.08–2.60) | ||
3rd | 29 (34.1) | 1.44 (0.90–2.31) | 1.18 (0.75–1.88) | ||
4th | 14 (16.9) | 0.71 (0.39–1.30) | 0.67 (0.37–1.21) | ||
Married/Cohabitingc | |||||
No | 53 (30.8) | 1 | 0.3 | 1 | 0.7 |
Yes | 45 (26.3) | 0.85 (0.61–1.20) | 0.94 (0.69–1.29) | ||
STDd | |||||
No | 80 (26.6) | 1 | 0.02 | 1 | 0.5 |
Yes | 18 (42.9) | 1.61 (1.08–2.40) | 1.15 (0.79–1.68) | ||
Number sexual partnersd | |||||
Up to 2 | 76 (26.4) | 1 | 0.03 | 1 | 0.2 |
3 or more | 22 (40.0) | 1.52 (1.04–2.21) | 1.25 (0.90–1.74) | ||
Use of intravenous drugsd,f | |||||
No | 70 (23.6) | 1 | 0.001 | 1 | 0.03 |
Yes | 28 (60.9) | 2.58 (1.89–3.52) | 1.45 (1.04–2.02) | ||
Use of inhaled illicit drugsd,f | |||||
No | 43 (18.5) | 1 | 0.001 | 1 | 0.001 |
Yes | 55 (49.5) | 2.67 (1.92–3.71) | 1.85 (1.28–2.68) | ||
Previous hepatitisd | |||||
No | 71 (25.8) | 1 | 0.02 | 1 | 0.5 |
Yes | 27 (39.7) | 1.54 (1.08–2.19) | 1.14 (0.80–1.60) | ||
Length of HIV infectione | |||||
Each year | 0.997 (0.965–1.031) | 0.9 | 0.989 (0.957–1.021) | 0.5 | |
Use of HAARTe | |||||
No | 7 (18.9) | 1 | 0.2 | 1 | 0.2 |
Yes | 91 (29.7) | 1.57 (0.79–3.13) | 1.69 (0.81–3.54) |
aLinear trend test; bHeterogeneity test; c1st level; d2nd level; e3rd level; ffinal model